Search research articles
Contact Us
Filters
Showing results (101-110 of 119) with videos related to
Page
of 12
Sort By:
Cellular and Molecular Biology (Noisy-Le-Grand, France)
|
May 17, 2001
Polyamines secreted by cancer cells possibly account for the impairment of the human erythrocyte sodium pump activity
P J Villano, P M Gallice, A E Nicoara, et al.
Cancer Research
|
April 1, 1997
Radioresistance induced by the high molecular forms of the basic fibroblast growth factor is associated with an increased G2 delay and a hyperphosphorylation of p34CDC2 in HeLa cells
E Cohen-Jonathan, C Toulas, S Monteil, et al.
Bone Marrow Transplantation
|
December 21, 2010
Tumor incidence in related hematopoietic stem cell donors
A Jeger, G Favre, J-M Lutz, et al.
The Journal of Biological Chemistry
|
July 15, 2000
RhoA prenylation is required for promotion of cell growth and transformation and cytoskeleton organization but not for induction of serum response element transcription
C Allal, G Favre, B Couderc, et al.
Contraception, Fertilite, Sexualite (1992)
|
January 10, 1998
[Value of a genetic evaluation before an intracytoplasmic sperm injection procedure]
C Hassan-Alkhadef, P Tourame, B Rossin-Amar, et al.
International Journal of Laboratory Hematology
|
August 27, 2009
Sideroblastic changes of the bone marrow can be predicted by the erythrogram of peripheral blood
A Rovó, G Stüssi, S Meyer-Monard, et al.
Proteome Science
|
March 21, 2012
Serum profiling by MALDI-TOF mass spectrometry as a diagnostic tool for domoic acid toxicosis in California sea lions
Benjamin A Neely, Jennifer L Soper, Denise J Greig, et al.
Radiation Research
|
September 9, 1999
The farnesyltransferase inhibitor FTI-277 suppresses the 24-kDa FGF2-induced radioresistance in HeLa cells expressing wild-type RAS
E Cohen-Jonathan, C Toulas, I Ader, et al.
Cancer Research
|
July 1, 1992
Low-density lipoprotein for delivery of an acrylophenone antineoplastic molecule into malignant cells
S Lestavel-Delattre, F Martin-Nizard, V Clavey, et al.
International Journal of Cancer
|
March 27, 2001
Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of human farnesyltransferase, BIM-46228
G P Prevost, A Pradines, M C Brezak, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 119) with videos related to
Sort By:
Page
of 12
Cellular and Molecular Biology (Noisy-Le-Grand, France)
|
May 17, 2001
Polyamines secreted by cancer cells possibly account for the impairment of the human erythrocyte sodium pump activity
P J Villano, P M Gallice, A E Nicoara, et al.
Cancer Research
|
April 1, 1997
Radioresistance induced by the high molecular forms of the basic fibroblast growth factor is associated with an increased G2 delay and a hyperphosphorylation of p34CDC2 in HeLa cells
E Cohen-Jonathan, C Toulas, S Monteil, et al.
Bone Marrow Transplantation
|
December 21, 2010
Tumor incidence in related hematopoietic stem cell donors
A Jeger, G Favre, J-M Lutz, et al.
The Journal of Biological Chemistry
|
July 15, 2000
RhoA prenylation is required for promotion of cell growth and transformation and cytoskeleton organization but not for induction of serum response element transcription
C Allal, G Favre, B Couderc, et al.
Contraception, Fertilite, Sexualite (1992)
|
January 10, 1998
[Value of a genetic evaluation before an intracytoplasmic sperm injection procedure]
C Hassan-Alkhadef, P Tourame, B Rossin-Amar, et al.
International Journal of Laboratory Hematology
|
August 27, 2009
Sideroblastic changes of the bone marrow can be predicted by the erythrogram of peripheral blood
A Rovó, G Stüssi, S Meyer-Monard, et al.
Proteome Science
|
March 21, 2012
Serum profiling by MALDI-TOF mass spectrometry as a diagnostic tool for domoic acid toxicosis in California sea lions
Benjamin A Neely, Jennifer L Soper, Denise J Greig, et al.
Radiation Research
|
September 9, 1999
The farnesyltransferase inhibitor FTI-277 suppresses the 24-kDa FGF2-induced radioresistance in HeLa cells expressing wild-type RAS
E Cohen-Jonathan, C Toulas, I Ader, et al.
Cancer Research
|
July 1, 1992
Low-density lipoprotein for delivery of an acrylophenone antineoplastic molecule into malignant cells
S Lestavel-Delattre, F Martin-Nizard, V Clavey, et al.
International Journal of Cancer
|
March 27, 2001
Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of human farnesyltransferase, BIM-46228
G P Prevost, A Pradines, M C Brezak, et al.
Page
of 12